Curaleaf Is A Better Cannabis Stock Now

(10min)

Summary

  • I am upgrading Curaleaf from Sell to Neutral due to its significantly lower price, despite ongoing balance sheet challenges.
  • Curaleaf's stock has plummeted 57.3% since I first called it out in January 2023, in line with broader cannabis market declines, but remains worse than its peers year-to-date.
  • Curaleaf's financials show minimal revenue growth and increased operating expenses, but improved cash flow from operations and potential upside if 280E taxation is eliminated.
  • Despite the downgrade in analyst expectations, Curaleaf's valuation is now more reasonable compared to peers, but Tier 2 MSOs offer more upside potential.
  • Looking for a helping hand in the market? Members of 420 Investor get exclusive ideas and guidance to navigate any climate. Learn More »

Directly Above Jar of Marijuana and Twenty Dollar Bills

HighGradeRoots

I am not a fan of Curaleaf (OTCPK:CURLF) (TSX:CURA:CA) relative to other cannabis stocks, but I am removing my Sell rating that has been in effect for almost two years. I am rating it Neutral now. In this

420 Investor launched in 2013, just ahead of Colorado legalizing for adult-use. We have moved the service to Seeking Alpha. Historically, we have provided great coverage of the sector with model portfolios, videos and written material to help investors learn about cannabis stocks, and we are excited to be doing it here!

This article was written by

72.27K Followers

Alan Brochstein, CFA, is one of the first investment professionals to focus exclusively on the cannabis industry. Alan got his start as a financial professional in the securities industry in 1986, managing investments in institutional environments until he founded AB Analytical Services in 2007 in order to provide independent consulting to registered investment advisors. He is also the managing partner of New Cannabis Ventures, a leading provider of relevant financial information in the cannabis industry since 2015.

Alan has run the investing group 420 Investor, for investors interested in the publicly-traded cannabis stocks that he moved to Seeking Alpha in 2023, since 2013. As the leader of the investing group 420 Investor, Alan closely covers 23 stocks and shares investment news as it comes out, previews of their earnings reports and analysis of them afterwards. Other features of the group include: 2 model portfolios, 10 videos per week with chart analysis, 3 summary pieces weekly, a monthly newsletter, and chat for questions Learn More. He also offers a sub-service of 420 Investor, The Big Picture, which will help you stay on top of the cannabis sector!

Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Recommended For You

About CURLF Stock

SymbolLast Price% Chg
Market Cap
PE
Yield
Rev Growth (YoY)
Short Interest
Prev. Close
Compare to Peers

More on CURLF

Related Stocks

SymbolLast Price% Chg
CURLF
--
CURA:CA
--